Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ana Maria Herrero-Beites"'
Autor:
Toni Merriman, Gorka Garcia Erauskin, Maria Angeles Aniel-Quiroga, Sandra P. Chinchilla, Ana Maria Herrero-Beites, Fernando Perez-Ruiz
Publikováno v:
Rheumatology International. 35:1519-1524
Inefficient renal excretion of uric acid is the main pathophysiological mechanism for hyperuricemia in gout patients. Polymorphisms of renal tubular transporters linked with sodium and monosaccharide transport have yet to be demonstrated. We intended
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb9f16492a1fd1e83aa2d06b8937238
https://doi.org/10.1007/s00296-015-3242-0
https://doi.org/10.1007/s00296-015-3242-0
Publikováno v:
Expert Review of Clinical Immunology. 10:339-347
The role of interleukin-1 (IL-1) in inflammation induced by crystals, and especially by monosodium urate crystals (MSUCs), has raised much interest in both basic and clinical investigation. Several drugs have been developed, and more are still in dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ae5549478c4b515af4ff30ac0ff425
https://doi.org/10.1586/1744666x.2014.880653
https://doi.org/10.1586/1744666x.2014.880653
Publikováno v:
Advances in Therapy. 29:935-946
Gout is a disease caused by deposition of monosodium urate crystals in tissues. One of the limitations for successful treatment of gout is to consider it as an intermittent disease rather than a chronic inflammatory disease which, if improperly treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e329f292df83f333a76abde1bf637403
https://doi.org/10.1007/s12325-012-0059-z
https://doi.org/10.1007/s12325-012-0059-z
Publikováno v:
Arthritis & Rheumatism. 63:4002-4006
It is commonly accepted that the target serum urate level in patients receiving urate-lowering therapy for dissolution of urate crystals in hyperuricemia of gout is6 mg/dl, and that patients with gout should continue urate-lowering therapy for the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ed51e24d3aaf8d174e466a14d74480
https://doi.org/10.1002/art.30649
https://doi.org/10.1002/art.30649
Autor:
Miguel A. González-Gay, Fernando Perez-Ruiz, Samuel Hernandez-Baldizon, Ana Maria Herrero-Beites
Publikováno v:
Arthritis Care & Research. 62:1299-1305
Objective To find factors associated with the development of renal colic during uricosuric therapy. Methods We performed a prospective cohort followup study of patients with gout and no previous history of kidney stones who had been treated with uric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::341e7e4b47b39108f26ca37f600373a1
https://doi.org/10.1002/acr.20221
https://doi.org/10.1002/acr.20221
This handbook discusses developments and the future of gout treatment, which looks promising. Gout has been a well-known disease for over 2000 years, and is the most common cause of joint inflammation in adult males. It has become apparent that no
Autor:
Ana Maria Herrero-Beites, Maria Angeles Aniel-Quiroga, Fernando Perez-Ruiz, Irati Urionagüena, Sandra P. Chinchilla, Joana Atxotegi
Publikováno v:
Rheumatology international. 35(11)
Increase in thyroid stimulating hormone (TSH) levels over the upper normal limit has been reported in a small percentage of patients treated with febuxostat in clinical trials, but a mechanistic explanation is not yet available. In an observational p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd51095b9e38c615343a3b970a73c16d
https://pubmed.ncbi.nlm.nih.gov/26342297
https://pubmed.ncbi.nlm.nih.gov/26342297
Autor:
Sofia Zarraga, Juan J. Amenabar, Joan M. Nolla, Fernando Perez-Ruiz, Ana Maria Herrero-Beites, M Calabozo, Pablo Gomez‐Ullate
Publikováno v:
Nephrology Dialysis Transplantation. 18:603-606
Background. Although hyperuricaemia and gout are frequently found in renal transplant recipients, little has been published on the efficacy of urate-lowering therapy (ULT) in this patient population. We therefore examine the effects of allopurinol an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53f315c0beaf62696c74135f094445d3
https://doi.org/10.1093/ndt/18.3.603
https://doi.org/10.1093/ndt/18.3.603
Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output
Publikováno v:
Scopus-Elsevier
Objective To compare renal handling of uric acid in patients with primary gout with that of a control group. Methods A case–control study of 100 patients with primary gout and 72 healthy controls was undertaken. Creatinine clearance, uric acid clea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19cc350a7390a34b81bc2682eb22a240
https://doi.org/10.1002/art.10792
https://doi.org/10.1002/art.10792